Development of a Gene Therapy Vector for RDH12-Associated Retinal Dystrophy. (2019)
Attributed to:
Development of an AAV vector for treatment of inherited retinal dystrophy caused by RPE65 deficiency
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1089/hum.2019.017
PubMed Identifier: 31237438
Publication URI: http://europepmc.org/abstract/MED/31237438
Type: Journal Article/Review
Volume: 30
Parent Publication: Human gene therapy
Issue: 11
ISSN: 1043-0342